Ozempic started the weight-loss drug frenzy, and it continues to be a famous name in the fight against obesity, but the FDA has issued a warning letter to its maker, Novo Nordisk, for failing to report potential side effects in patients who took this medication
If you have recently transitioned from standard lifestyle changes to a personalized weight loss program, you may find yourself staring at a vial and a syringe, wondering exactly how to measure your dose
But to do that, we need lower prices, thoughtful coverage policies, and a clearer understanding of who benefits most. Lifetime Health Effects and Cost-Effectiveness of Tirzepatide and Semaglutide in US Adults was published in JAMA Health Forum in March 2025
Probiotic supplementation promotes intestinal microbial homeostasis
The most common first-time medication was semaglutide (n = 644,272)